Iyintoni i-Mass Adnexal?

Ukukhula okungavumelekanga kweziTyhufu kufuphi ne-Ovari

Ubunzima be-adnexal bubunzima obungavamile obusondela kwisibeleko, esivame ukuvela kwii-ovaries, i-fallopian tubes, okanye izicubu ezinxulumene. Ubunzima obufana nobunzima bunokuba yi-cystic (igcwaliswe ngamanzi) okanye iqinile. Nangona amaninzi amaninzi e-adnexal aya kuba nonobungozi (ongenomdlavuza), ngamanye amaxesha angaba yingozi (umdlavuza).

Izidumbu ze-Adnexal zenzeka nanini na ubudala, nangona zibonakala ngokubanzi kubasetyhini beminyaka yobudala.

Iimbangela zeMisa ye-Adnexal

Kukho izizathu ezininzi zokuba kutheni ukukhula kwe-adnexal kungakhula. Kubabhinqa be-premenopausal, bahlala behlanganiswa ne- ovarian cysts , izicubu ze-ovarian, i- endometriosis , i- polycystic ovary syndrome (i-PCOS) , ukukhulelwa kwe-ectopic (tubal), kunye nomhlaza we-ovari.

Ekubeni ama-adnexal masses aqhelekanga, oogqirha kufuneka baqwalasele iinkalo eziliqela ukucacisa isizathu kunye nokuhlelwa kohlumo. Nangona umdlavuza ungomnye wezinto ezininzi ezinokubangela, iiflegi ezibomvu ziphakanyiswa ukuba:

Ukuxilongwa

Ukuba ubunzima be-adnexal bufumaneka ngexesha lovavanyo lomzimba, kukho iimvavanyo ezininzi zokucinga eziza kunceda ekuxilweni, kuquka:

Uvavanyo lokukhulelwa lunokwenziwa kwakhona ukuze luncede ukufumanisa ukukhulelwa kwe-tubal. Ukuba isifo somhlaza se-ovariya sikhankanywe, uvavanyo lwe- CA 125 (olulinganisa iprotheni, olubizwa ngokuba ngumhlaza we-antigen 125, egazini) linokuyalelwa.

Ukuba ubunzima buyi-cystic, ugqirha unokwenza umnqweno wokukhenkceza amanzi kunye nenaliti.

Nangona kunjalo, oogqirha abaninzi baya kuphepha le nto, ingakumbi ukuba umhlaza uphankanywe, kuba i-fluid ekhutshiwe ingaba neeseli ezinobungozi ezingakwazi ukuhluma ezinye izifo.

Ulawulo kunye neNyango

Ngokusekelwe kwiziphumo zokuqala, ugqirha unokuthatha indlela yokulinda nokulinda, ukubeka iliso rhoqo nayiphi na utshintsho ubunzima, okanye uqalise ukungenelela kwangangoko. Oku kungabandakanya ukususwa koxinzelelo obuninzi olulandelwe ukuvavanywa kwebhu.

Xa kwenzeka ukukhulelwa kwe-tubal, unyango olungxamisekileyo lunokufunwa ukukhusela ukuphuka komngcipheko wokuphila, ingakumbi ukuba loo ntokazi ibonakalisa uphawu.

Kwiimeko ezininzi, nangona kunjalo, ubunzima be-adnexal abuyi kuba yimbangela ye-alarm kwaye angeze banikeze nayiphi na ingxaki zempilo kulo mfazi.

Xa kuthethwa oko, oogqirha baya kugxininisa ngakumbi nawuphi na amaninzi okanye izilonda ezivela okanye zijikeleze ii-ovari okanye kwiibhulo ze-fallopian. Ucwaningo luye lwabonisa ukuba ukukhula kwizibilini ze-fallopian ngokuqhelekileyo kusebenza njengama-precursors kuma-serous ovarian carcinomas (HGSOC) kwiminyaka ephezulu. I-akhawunti ye-HGSOC malunga neepesenti ezingama-75 zazo zonke ii-cancer ze-ovari

ILizwi

Ukuba ubunzima be-adnexal bunokufunyanwa kwaye umdlavuza uyakrokrelwa, kusoloko kulungele ukufumana ukhetho lwesibini kwi-oncologist ye-gynecologic eya kuba nolwazi oluninzi kwi-diagnostic, staging , kunye nonyango lwe-endometrial kunye ne-ovarian cancers.

Ngokubanzi, amaxesha okuphila kwabasetyhini abangaphantsi kwe-gynecologic oncologist iya kuba mkhulu kunabo baphathwa ngugqirha jikelele.

Nangona ubunzima be-adnexal buya kuba buhlungu, i-oncologist ye-gynecologic iya kuba ngcono ukukwazi ukuba ngaba utshintsho kwi-warrant yokukhula luncedo kangakanani.

> Imithombo:

> Chan, K; USherman, A; Zapp, D. "Impembelelo ye-gynecologic oncologists ekusindeni kwezigulane ezine-cancer ye-endometrial." J Clin Oncol. 2011; 29 (7): 832-8. INGXELO: 10.1200 / JCO.2010.31.2124.

> Dodge, J. "Ulawulo lwe-adnexal mass: isikhokelo somsebenzi wekliniki." Curr Oncology . 2012; 19 (4): e244-57. INGXELO: 10.3747 / co.19.980.

> ULabidi-Galy, S .; Papp, E .; Hallberg, D. et al. "I-grade grade serous ovarian carcinomas ivela kwi-tube fallopian." Nat Commun. 2017; 8: 1093. INGXELO: 10.1038 / s41467-017-00962-1.

> USuh-Burgmann, E. kunye noKinney, W. "Iingozi ezibonakalayo zingaphezu kweenzuzo ezingapheliyo zokubeka esweni ngokungapheliyo kwezinto ezizinzileyo ze-adnexal." Amer J Gstecol Obstetric . 2015; 213 (6): 816.e1-4. INGXELO: 10.1016 / j.ajog.2015.09.005.